SAR444881 Clinical Trials

1 actively recruiting trial across 1 location

Filter by location:

Houston, Texas1 trial

Phase II Biomarker Study of SAR444881 in Combination With Cemiplimab in Solid Tumors

Md Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.